FNDC5 and metabolic dysfunction-associated steatotic liver disease: In addition, the administration of nicotinamide ribose to mice with NAFLD has been shown to increase the plasma FNDC5/irisin levels as well as FNDC5 deubiquitination and deacetylation via sirtuin 2 for the treatment of NAFLD (Li et al., 2021).